The Duty to Disclose Adverse Clinical Trial Results

By Liao S. Matthew   Sheehan Mark   Clarke Steve  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 24-32

Routledge Ltd

Access to resources Recommend Favorite

Enhancing Informed Consent in Clinical Trials and Exploring Resistances to Disclosing Adverse Clinical Trial Results

By Banja John   Dunlop Boadie  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 39-41

Routledge Ltd

Access to resources Recommend Favorite

Disclosure of Adverse Clinical Trial Results—Should Legal Immunity Be Granted to Drug Companies?

By Vernillo Anthony  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 45-47

Routledge Ltd

Access to resources Recommend Favorite

Improving Subject Recruitment By Maintaining Truly Informed Consent: A Practical Benefit of Disclosing Adverse Clinical Trial Results

By Shah Kavita   Batzer Frances  

American Journal of Bioethics, Vol. 9, Iss. 8, 2009-08 ,pp. : 36-37

Routledge Ltd

Access to resources Recommend Favorite

Should Researchers Disclose Results to Descendants?

By Rothstein Mark A.  

American Journal of Bioethics, Vol. 13, Iss. 10, 2013-10 ,pp. : 64-65

Routledge Ltd

Access to resources Recommend Favorite